Literature DB >> 20430902

Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa.

R S Bradbury1,2, L F Roddam1, A Merritt3, D W Reid4,1, A C Champion1.   

Abstract

The virulence factor genotypes of a large cohort of clinical, nosocomial environment and community environment isolates (184 in total) of Pseudomonas aeruginosa from Tasmania, Australia, were determined by PCR. The virulence factor genotype of the majority of isolates was highly conserved, with the exception of the virulence gene exoU, which demonstrated low prevalence (33 isolates; 18 %) in the population tested. Isolates collected from the environment of intensive therapy wards (intensive care unit and neurosurgical units) of the major tertiary referral hospital in Tasmania were found to be more likely (P<0.001 and P<0.05, respectively) to possess the virulence factor gene exoU than all other isolates. Adult cystic fibrosis isolates showed a decreased prevalence of the exoU gene (P<0.01) when compared to other clinical isolates (P<0.01), which may indicate decreased virulence. No specific virulence factor genotype was associated with the cystic fibrosis epidemic strains tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430902     DOI: 10.1099/jmm.0.018283-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  28 in total

1.  Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.

Authors:  S J Kaiser; N T Mutters; A DeRosa; C Ewers; U Frank; F Günther
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-12       Impact factor: 3.267

2.  Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.

Authors:  Durga S Borkar; Suzanne M J Fleiszig; Chelsia Leong; Prajna Lalitha; Muthiah Srinivasan; Avanti A Ghanekar; Connie Tam; Wing Y Li; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

3.  Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa.

Authors:  Victoria Rutherford; Kelly Yom; Egon A Ozer; Olivia Pura; Ami Hughes; Katherine R Murphy; Laura Cudzilo; David Mitchell; Alan R Hauser
Journal:  Environ Microbiol Rep       Date:  2018-08       Impact factor: 3.541

4.  Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.

Authors:  Noha A Hassuna
Journal:  Surg Infect (Larchmt)       Date:  2016-07-21       Impact factor: 2.150

Review 5.  Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.

Authors:  Teiji Sawa; Masaru Shimizu; Kiyoshi Moriyama; Jeanine P Wiener-Kronish
Journal:  Crit Care       Date:  2014-12-13       Impact factor: 9.097

6.  A novel multiplex PCR for detection of Pseudomonas aeruginosa: A major cause of wound infections.

Authors:  Muhammad Salman; Aamir Ali; Abdul Haque
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

7.  The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.

Authors:  Arshid Yousefi-Avarvand; Reza Khashei; Hadi Sedigh Ebrahim-Saraie; Amir Emami; Kamiar Zomorodian; Mohammad Motamedifar
Journal:  Int J Mol Cell Med       Date:  2015

8.  Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections.

Authors:  Nastaran Fazeli; Hassan Momtaz
Journal:  Iran Red Crescent Med J       Date:  2014-10-05       Impact factor: 0.611

9.  Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates.

Authors:  Jonida Toska; Yan Sun; Dalina Alvarez Carbonell; Altreisha N-S Foster; Michael R Jacobs; Eric Pearlman; Arne Rietsch
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa.

Authors:  Yuji Morita; Ken-Ichi Nakashima; Kunihiko Nishino; Kenta Kotani; Junko Tomida; Makoto Inoue; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2016-08-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.